GRGhorbanali Rahimian

Ghorbanali Rahimian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ghorbanali Rahimian has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Analysis of Interleukin 22 Gene Expression in Helicobacter pylori -Infected Patients With Inflammation and Peptic Ulcer Compared to Uninfected Controls

    by Mehrnoosh Haghighian, Noosha Zia Jahromi, Ghorbanali Rahimian

    Background and aims: Inflammation is a key feature of Helicobacter pylori infection and its associated complications, gastritis, and gastrointestinal ulcers. This study aimed to determine the level of expression of interleukin (IL)-22 in the gastric mucosa in the control group and patients with gastritis and peptic ulcer. Methods: This case-control study was conducted on patients with gastrointestinal problems referred to the endoscopy unit of Hajar Hospital of Shahrekord (Iran, 2018). Overall, 135 tissue samples were collected from people suspected of gastritis (n=45), people with peptic ulcers infected with H. pylori (n=45), and people without H. pylori infection (n=45). IL-22 gene expression was measured using a real-time polymerase chain reaction method compared to the beta-actin internal gene. IL-22 expression was calculated by 2-ΔΔct and statistically analyzed by SPSS16 software and t-student test. Results: In this research, the mean age of the patients was 50.17±15.09 and 50.96±19.77 in the infected and non-infected groups, respectively. There was no significant difference between the two studied groups in terms of age and gender (P=0.236). IL-22 expression in H. pylori-infected individuals (3.21±0.58) was 3.54-fold higher than that in the control group (0.9±0.14, P=0.036). Likewise, IL expression in peptic ulcer (2.2±0.43) was significantly higher than that in those with gastritis (1.12±0.87, P=0.012). Conclusion: Despite its pro-inflammatory nature, IL-22 can effectively control bacterial infections and strengthen mucosal defenses, particularly in the context of H. pylori infection, highlighting its therapeutic potential.

  • The Biological Effects and Mechanisms of Fisetin on Hepatotoxicity, Liver Injury and Liver Fibrosis: A Systematic Review

    by Ghorbanali Rahimian, Saeid Heidari-Soureshjani, Karamali Kasiri

    Background: Liver disease is a common cause of death worldwide. Objectives: This study aims to investigate the effects and mechanisms of Fisetin on hepatotoxicity, liver injury, and liver fibrosis. Methods: We adhered to the PRISMA 2020 guidelines in this systematic review. Our search used MeSH keywords encompassed Embase, PubMed, Web of Science, Scopus, and Cochrane Library for articles published before March 2, 2024. Relevant data was extracted from the publications, meticulously recorded in a standard form, and subsequently reviewed for outcomes and mechanisms. Results: Fisetin protects hepatocytes from oxidative stress by neutralizing free radicals (O2 −and H2O2), reduces oxidative stress, prevents lipid peroxidation, and increases endogenous antioxidants. It also reduces inflammation via lowering the production of tumor necrosis factor α (TNF-α), interleukins (IL)1α, IL-6, IL-18, IL-1β suppressing nuclear factor kappa B (NF-κB) activation, and cyclooxygenase- 2 (COX-2), inducible nitric oxide synthase (iNOS) inhibition, reducing monocyte chemoattractant protein-1 (MCP-1), plasminogen activator inhibitor 1 (PAI-1), NLR family pyrin domain-containing 3 (NLRP3) inflammasome and interferon-gamma (IFN‐γ). Moreover, it inhibited apoptosis-modulated enzyme activity and detoxification enzymes via modulating the activity of cytochrome P450 and Phase II detoxification enzymes. Fisetin prevented fibrosis by inhibiting the activation of hepatic stellate cells (HSCs), attenuating extracellular matrix (ECM) remodeling-associated genes, and suppressing transforming growth factor-β (TGF-β) signaling pathway and attenuating collagen production. It decreased lipid accumulation and liver function tests. Conclusion: In vivo and in vitro studies indicated that Fisetin can enhance detoxification, attenuate liver injury, and reduce fibrosis, which helps maintain liver health.


  • The Association between Gallstone Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis

    by Rasoul Rahimi, Saeid Heidari-Soureshjani, Catherine Mt Sherwin, Karamali Kasiri, Ghorbanali Rahimian

    Background: Gallstone Disease (GSD) is a multifactorial risk factor for various complications. Objective: This study aimed to examine the relationship between GSD and Cardiovascular Disease (CVD) through a systematic review and meta-analysis approach. Methods: A thorough search was conducted across Web of Science, Scopus, MEDLINE/PubMed, Cochrane Library, and Embase databases. Only studies published between 1980 and December 2023 were included. Chi-square, I2, and forest plots were used to assess heterogeneity. Begg's and Egger's tests were used to evaluate publication bias. Statistical significance was considered at p <0.05, and all analyses were performed using Stata 17. Results: This meta-analysis involved 21 studies and comprised 2,138,282 participants; there has been a significant association found between GSD and an increased risk of CVD (with a relative risk of 1.46, 95% confidence interval: 1.32-1.63, p <0.001). The analysis found no evidence of publication bias based on Begg's test (p =0.085) and Egger's test (p =0.231). Subgroup analysis of the studies showed a higher risk of CVD in studies with a sample size of less than 10,000 participants, conducted in 2016 or later, utilizing a cross-sectional design, in Asian countries; the analysis had a moderate quality score, with a follow-up period of equal to or less than ten years. Conclusion: There has been a significant association found between GSD and CVD and their incidence is related to each other. Taking proactive steps to implement targeted interventions for individuals with gallstone disease could potentially reduce the risk of cardiovascular disease within this population.


  • Open Access

    A systematic review of polyphenols therapeutic and preventive role in cholelithiasis

    by Hossein Mardani-Nafchi, Ghorbanali Rahimian, Ali Amini, Iraj Baratpour

    Introduction: Gallstone disease (GSD) or cholelithiasis has become prevalent in recent years and can increase the risk of gallbladder cancers. This systematic review study investigates the effects of polyphenols in preventing and treating GSD and its associated complications. Methods: An extensive search of the available literature was performed for articles published since 5/20/2024 using multiple databases, including PubMed, Scopus, Web of Science, Embase, and Cochrane Library, using polyphenols, phenolic compounds, gallstones, and cholelithiasis-related keywords. After screening the records, data were extracted, and the most important outcomes were reviewed. Results: Polyphenols reduce the levels of ABCG5/8 in the liver and decrease the expression of Niemann-Pick C1-like 1 (NPC1L1) and sterol regulatory element-binding protein 2 (SREBP2) in the intestine. Additionally, the upregulation of the CYP7A1 gene may help regulate various genes, enzymes, and proteins, potentially leading to GSD. They also reduce the cholesterol saturation index (CSI), bile salts, phospholipids, lipid peroxidation, and malondialdehyde (MDA) levels. They also increase glutathione (GSH) levels and alleviate edema in the gallbladder wall. Additionally, polyphenols inhibit the action of 5-Lipoxygenase (a lipid mediator of inflammation), nuclear factor kappa B (NF-κB), peroxisome proliferator-activated receptor-γ (PPAR-γ), and cyclooxygenase-2 (COX-2). These actions contribute to their antioxidant and anti-inflammatory properties in relation to GSD. They also prevented GSD by modulating gut microbiota and improving histopathological changes. Conclusion: Polyphenols have potentially protective effects against GSD incidence. Further clinical studies are necessary before they can be used in clinical settings.


  • Biological Mechanisms of Polyphenols against Clostridium Difficile: A Systematic Review

    by Mohammad Darvishi, Seyed Mahmoud Reza Hashemi Rafsanjani, Majid Nouri, Saber Abbaszadeh, Saeid Heidari-Soureshjani, Karamali Kasiri, Ghorbanali Rahimian

    Background: Clostridium difficile is an opportunistic infection that can lead to antibi-otic-associated diarrhea and toxic megacolon. Objective: This systematic review study aimed to investigate polyphenols' antibacterial and anti-toxin properties and their effects on reducing complications related to C. difficile Infections (CDI). Methods: This systematic review was conducted following the PRISMA guideline 2020. Multiple databases, including Web of Science, PubMed, Cochrane Library, EMBASE, and Scopus, were searched thoroughly for existing literature. After considering the inclusion and exclusion criteria for the review, 18 articles were included. Data were collected and registered into an Excel file for further investigations and conclusions. Results: Polyphenols by reducing Reactive Oxygen Species (ROS) levels, increasing inflammatory factor Interleukin 10 (IL-10), reducing Nuclear Factor kappa B (NF-κB) and Tumour Necrosis Fac-tor-α (TNF-α), IL-6, IL-1α, IL-1β, Granulocyte Colony-stimulating Factor (G-CSF), and Monocyte Chemoattractant Protein-1 (MCP-1) and Macrophage Inflammatory Protein-1 alpha (MIP-1α) lev-els, and regulating the expression of Bcl-2 and Bax, make the growth and replication conditions of C. difficile more difficult and prevent it from producing toxins. Furthermore, polyphenols can ex-hibit prebiotic properties, promoting the growth of beneficial Bifidobacterium and Lactobacillus species and consequently regulating gut microbiota, exerting antimicrobial activities against C. dif-ficile. They also induce their beneficial effects by inhibiting the production of C. difficile TcdA and TcdB. Conclusion: Polyphenols have been reported to inhibit C. difficile growth and toxin production by several mechanisms in preclinical studies. However, more clinical studies are needed to investigate their safety in humans.


  • Open Access

    Association Between Gallstone Disease and Kidney Stone Disease: A Systematic Review and Meta-analysis

    by Faramarz Beigi, Alizamen Salehifard Jouneghani, Saeid Heidari-Soureshjani, Catherine Mt Sherwin, Ghorbanali Rahimian

    Background and aims: Gallstone disease (GSD) and kidney stone disease (KSD) have increased due to lifestyle in recent decades. This systematic review and meta-analysis aimed to investigate the association between these two diseases. Methods: A comprehensive electronic database search was conducted before August 25, 2024. This systematic review and meta-analysis included observational studies. The meta-analysis employed a random-effects model to compute the overall summary estimates of the association between GSD and KSD using risk ratios with 95% confidence intervals (CIs) as the primary measure of the effect size. Heterogeneity was evaluated using chi-square tests, the I² statistic, and forest plots. Publication bias was assessed through Begg’s and Egger’s tests. A P value of less than 0.05 was considered statistically significant, and all analyses were performed using Stata 17 software. Results: The meta-analysis included 9 studies encompassing 982847 participants. The pooled analysis revealed a statistically significant association between GSD and KSD, with a risk of 1.78 (95% CI: 1.572.03, P≤0.001). Begg’s and Egger’s tests demonstrated no significant bias (Begg’s test P=0.835, Egger’s test P=0.812). Variables such as study year, sample size, mean age of participants, mean follow-up, and study quality as determined by the Newcastle-Ottawa Scale (NOS) were examined, but none could significantly impact heterogeneity (P>0.10). Conclusion: This systematic review and meta-analysis provide evidence of a significant association between GSD and KSD. Therefore, further investigation into the underlying mechanisms and potential risk factors is necessary.


  • Open Access

    Risk Factors for Ulcerative Colitis in Shahrekord, Iran: A Case-Control Study

    by Hamid Gheibipour, Ghorbanali Rahimian, Ali Ahmadi

    Background and aims: Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) which involves the rectum and colonic mucosa, and is often constantly expanding. Few data are available on risk factors in Chaharmahal and Bakhtiari province. Therefore, the aim of this study was to investigate the association between potential risk factors and UC in Shahrekord. Methods: A case-control study was conducted on patients diagnosed with UC. Overall, 27 new cases of UC and 54 healthy controls in the age range of 20–80 years were studied. Participants were recruited from Pathologic Centers in Shahrekord in 2018. Chi-square test and t test and were used. Logistic regression model was employed to analyze the association between risk factors and UC disease. Results: The mean age at diagnosis was 41.74 years (SD: 7.16 years) and 44.94 years (SD: 6.67 years) for case and control subjects, respectively. Moreover, univariate and multiple odds ratio (OR) showed that there was no significant association between UC and any of the risk factors including gender, marital status, education, diastolic blood pressure, history of diabetes, history of hypertension, permanent use of piped water, night shift work, history of thyroid diseases, depression, history of fatty liver disease, history of kidney stones, and sleep time and wake-up time in the morning. Conclusion: Generally, no significant association was observed between UC and the variables in the present study. Thus, further studies with larger sample size are necessary to better understand the other risk factors and environmental determinants of UC.

  • Altered Th17 Cytokine Expression inHelicobacter pyloriPatients with TLR4 (D299G) Polymorphism

    by Nader Bagheri, Fatemeh Azadegan-Dehkordi, Ghorbanali Rahimian, Morteza Hashemzadeh-Chaleshtori, Mahmoud Rafieian-Kopaei, Soleyman Kheiri, Abolfazl Gholipour, Hedayatollah Shirzad

    Helicobacter pylori (H. pylori) is associated with gastric ulcer and gastric adenocarcinoma. Polymorphisms in the host genes coding for Toll-like receptors (TLRs) may influence the innate and adaptive immune response to the infection, affecting the susceptibility to H. pylori or the disease outcomes. However, the details and association with different polymorphism and clinical expression of infection remain unclear. A case-control study consisting of 58 patients with H. pylori infection and 44 H. pylori uninfection was conducted. Genomic DNA was extracted and genotypes of TLR4 Asp299Gly polymorphism were assessed through polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Mucosal cytokines expression in H. pylori-infected and uninfected gastric biopsies was determined by real-time PCR. The expression of IL-6, IL-17, IL-21, IL-23 and TGF-β1 was significantly higher in patients with D299G polymorphism in TLR4. But the expression of IL-18 between patients with single-nucleotide polymorphisms (SNPs) in TLR4 and patients with the wild-type allele was not significant. In H. pylori-infected patients with gastritis, SNPs in TLR4 may alter cytokine expression toward Th17 immune response in the gastric mucosa and may have increased risk for the development of peptic ulcer.


  • Open Access

    Comparative Immune Response in Children and Adults withH. pyloriInfection

    by Alireza Razavi, Nader Bagheri, Fatemeh Azadegan-Dehkordi, Mahsa Shirzad, Ghorbanali Rahimian, Mahmoud Rafieian-Kopaei, Hedaytollah Shirzad

    Helicobacter pylori(H. pylori) infection is generally acquired during early childhood; therefore, the immune response which usually takes place at this age may influence or even determine susceptibility to the infection contributing to the clinical outcomes in adulthood. Several cytokines including IL-6, IL-10, and TGF-β1 as well as Foxp3+cell numbers have been shown to be higher; however, some other cytokines consisting of IL-1β, IL-17A, and IL-23 are lower in infected children than in infected adults. Immune response toH. pyloriinfection in children is predominant Treg instead of Th17 cell response. These results indicate that immune system responses probably play a role in persistentH. pyloriinfection. ChildhoodH. pyloriinfection is also associated with significantly lower levels of inflammation and ulceration compared with adults. This review, therefore, aimed to provide critical findings of the available literature about comparative immune system in children and adults withH. pyloriinfection.


  • Open Access

    Clinical immunologyMucosal interleukin-21 mRNA expression level is high in patients with Helicobacter pylori and is associated with the severity of gastritis

    by Nader Bagheri, Fatemeh Azadegan-Dehkordi, Mahsa Shirzad, Benham Zamanzad, Ghorbanali Rahimian, Afshin Taghikhani, Mahmoud Rafieian-Kopaei, Hedayatollah Shirzad

    Helicobacter pylori (H. pylori) infection is associated with gastritis and marked infiltration of the gastric mucosa by several cytokines secreting inflammatory cells. Different clinical forms of the infection may reflect distinctive patterns of cytokine expression. Interleukin (IL)-17, IL-21, IL-22, and IL-23 have been reported to be involved in H. pylori-induced gastric mucosal inflammation, but the details and relationship to different patterns of inflammation and virulence factors remain unclear. The present study was launched to analyse IL-6 expression in H. pylori-infected and uninfected gastric patients and to investigate its correlation with chronic gastritis among H. pylori-infected patients. Total RNA was extracted from the gastric antrum biopsies of 48 H. pylori-infected patients and 38 H. pylori uninfected patients. Mucosal IL-21 mRNA expression level in H. pylori-infected and uninfected gastric biopsy was determined by real-time PCR. The presence of vacA (vacuolating cytotoxin A) and cagA (cytotoxin associated gene A) virulence factors were evaluated using PCR. Interleukin-21 mRNA expression was significantly high in biopsies of H. pylori-infected patients compared to H. pylori uninfected patients, and the mucosal IL-21 mRNA level was positively correlated with the grade of chronic inflammation. There was no association between virulence factors and IL-21 mRNA expression. We believe that IL-21 might be involved in the pathogenesis of H. pylori and might be an index of the severity of chronic gastritis.